Whole grain wheat consumption affects postprandial inflammatory response in a randomized controlled trial in overweight and obese adults with mild hypercholesterolemia in the Graandioos Study
The Journal of Nutrition Sep 05, 2019
Hoevenaars FPM, Esser D, Schutte S, et al. - Researchers examined the influence of whole grain wheat (WGW) consumption on health by quantifying the body's resilience, defined as the “ability to adapt to a standardized challenge”, in this double-blind randomized controlled trial including overweight and obese (BMI: 25–35 kg/m2) men (n = 19) and postmenopausal women (n = 31) aged 45–70 y, with mildly raised plasma total cholesterol (> 5 mmol/L). Either WGW (98 g/d) or refined wheat (RW) was consumed by the participants for 12 wks, using randomized allocation. A standardized mixed-meal challenge was carried out prior to and following the intervention. They assessed intervention results as composite markers representing the resilience of inflammation, liver, and metabolism, using health space models. RW was shown to induce diminished inflammatory and liver resilience, whereas WGW rejuvenated liver resilience, by health space visualization. Findings revealed the capability of 12-wk 98 g/d WGW intake in promoting liver and inflammatory resilience in overweight and obese people with mildly raised plasma cholesterol. To assess intervention impacts as composite markers, the health space approach seemed suitable.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries